The executive director of the Drug Policy Alliance explains how US funding cuts will affect addiction treatment, overdose prevention, and other harm reduction services.
Zolopa et al. identify predictive factors of overdose requiring an emergency response at SIS in Montréal, including gender identity, age, housing status, and frequency and nature of use.
While such tariffs may seem a persuasive political message, they hinder bilateral engagement, defer blame, and perpetuate the very problems they claim to address.
Ontario's legislative action to close safe consumption sites risks undermining the achievements of these initiatives, including saving lives, increasing community safety and HIV/Hepatitis control.
Lavalley et al. call for responses to Canada's overdose epidemic to centre the ongoing impacts of structural violence, colonialism and poverty that perpetuate inequalities faced by Indigenous communities.
Prioritising harm reduction efforts, public health and safeguarding rights are key to combatting rising opposition to Canada's historically bold drug policies and increasingly toxic supply.
D4DPR argues that money from opioid litigation settlements should also be used for overdose prevention centres to mitigate future death and mortality and improve the quality of life for those who use drugs.
Recent statistics show a decline in US overdose deaths, but these rates are most likely rising in racialised minority communities due to disproportionate criminalisation and resource scarcity.
DULF founders say shutting down compassion clubs poses great risks to people who use drugs by denying them access to safe supply amidst a drug deaths catastrophe.
In light of the grave threats posed by nitazenes in Australia, experts call for political support and scaling-up of drug checking services to reduce fatalities.
